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Abstract 
Accurate identification of the microscopic risk factors of oral and oropharyngeal (OP) squamous cell carcinomas 
(SCC) and their morphologic variants is of at most importance, as these generally determine treatment modalities, 
prognosis and overall patient outcome. The great majority of oral and oropharyngeal squamous cell carcinomas 
are microscopically described as kerartinizing squamous cell carcinoma (KSCC). They bear certain resemblance 
to keratinizing stratified squamous epithelium. Tobacco habits and excessive consumption of alcoholic beverages 
have been considered to be the main etiologic agents in these carcinomas. The tumors occurred in older patients 
more commonly affected the oral tongue and floor of the mouth with well established morphologic risk factors 
including tumor grade, pattern of invasion and perineural involvement. 
Within the last 30 years however, the advent and expanding prevalence of high risk human papillomavirus (HPV) 
as an important etiologic agent for head and neck squamous cell carcinoma, particularly in the OP, has resulted 
in a significant change in the established morphologic criteria for risk assessment. The majority of HPV relate 
carcinomas of the OP are nonkeratinizing squamous cell carcinoma (NKSCC). These tumors are found to be more 
responsive to treatment with a favorable patient outcome and good prognosis. Consequently, alterations in treat-
ment protocols aimed at de-escalation are currently being evaluated. More recently, other morphologic variants 
that are HPV positive are reported with increasing frequency in the OP and other head and neck sites. As a result, 
several clinical and pathologic questions have emerged. Importantly, whether the virus is biologically active in 
these tumors and involved in their pathogenesis, and second, what are the clinical implications with regard to 
patient management and outcome in the HPV-related variants. 
Examples of HPV-related squamous cell carcinoma variants that will be addressed here are: basaloid squamous 
cell carcinoma (BSCC), undifferentiated carcinoma (UCa), papillary squamous carcinoma (PSCC) and small cell 
carcinoma. Some studies have suggested favorable prognosis in some variants, analogous to that of the (NKSCC), 
while others showed poorer outcome.   So far the number of studies on this subject is limited and the number of 
cases evaluated in each investigation is few. Because of that, it is prudent at this stage, not to alter management 
protocols as a result of identification of HPV in these variants and to await additional information. 
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Keratinizing squamous cell carcinoma (KSCC); 
morphologic risk factors
Traditionally KSCCs have been graded according to 
their state of differentiation and resemblance to normal 
squamous epithelium into well, moderate and poorly 
differentiated variants. The grading system which was 
originally proposed by Broder (1) was based on the 
amount of keratin production and pleomorphism of the 
tumor cells. However, because the morphologic fea-
tures can vary considerably from area to area within the 
same tumor, the Broder grading system was found to 
lack significant prognostic value. Several authors sug-
gested that more useful prognostic information may be 
deduced from the invasive fronts of the tumors where 
the deepest and presumably more aggressive cells re-
side (2,3). According to this system fi ve histologic fea-
tures are graded and assigned scores from one to four. 
The scores for all the variant are summed to provide 
a total malignancy score for a particular tumor. The 
parameters used are: degree of keratinization, nuclear 
pleomorphism, number of mitosis per high power field 
(HPF), pattern of invasion and inflammatory lympho-
plasmacytic host response. The highest scores are given 
to tumors with low or no keratinization, extreme nu-
clear pleomorphism, >5 mitosis/HPF, marked cellular 
dissociation in small nests and single cells and no host 
response. 
A newer risk model was developed by Brandwein-
Gensler and associates (4-�) as an extension and modifi -
cation of prior multivariable histologic systems analyz-
ing the advancing tumor front. In this model a risk cat-
egory is assigned by examining the resection specimen 
of the primary tumor and quantifying 3 significant his-
tologic variables; 1- Pattern of invasion at the advanc-
ing tumor edge (PI). The different types of patterns are 
described as; pushing border, finger like growth, large 
islands, small islands or distant satellites. 2- Perineural 
invasion (PNI) involving either small nerves or large 
ones (� 1mm). 3- Lymphocytic host response at the ad-
vancing tumor edge described as strong, intermediate 
or weak. The risk model classified the tumors, accord-
ing to a point score into low, intermediate, and high risk 
groups which correlated significantly with local recur-
rence rates and overall survival in a cohort of patients 
with head and neck squamous cell carcinoma (5).  The 
prognostic value of this risk model was further validat-
ed in patients with low-stage (Stag I/II) oral squamous 
cell carcinoma. The model was significantly predictive 
of loco-regional recurrence and disease specific sur-
vival (�). Based on these observations it was suggested 
that some low stage oral SCC that would traditionally 
be treated surgically may benefit from adjuvant radio-
therapy if classified in the high risk group. Tumor thick-
ness in oral KSCC has also been used as a parameter 
for outcome prediction in T1 carcinomas. However, it 
was found that the cut-off tumor thickness varied by 
anatomic site. In addition, it predicted lymph node me-
tastasis and survival but not local recurrence.
HPV-Related squamous cell carcinoma 
During the last 30 years accumulating epidemiologic and 
clinical evidence has shown that high risk human papil-
lomavirus (HPV) is a major etiologic factor in a subset 
of head and neck squamous cell carcinomas. These tu-
mors have distinct clinical, microscopic and molecular 
features. The greatest majority of the carcinomas occur 
in the OP, particularly the palatine and lingual tonsils 
areas. They are characterized by younger age at onset 
(7), weak or no association with alcohol and tobacco 
use but strong association with sexual behavior, particu-
larly oral sex  (8,9). Despite a characteristic early lymph 
node metastasis, HPV-related oropharyngeal squamous 
cell carcinomas are associated with significantly better 
treatment outcome and patient survival (10-12).
Microscopically, HPV-related squamous cell carcinoma 
of the OP are distinguished by a nonkeratinizing mor-
phology (7,11,13). The tumors are characterized by rela-
tively monomorphic, ovoid and spindle-shaped basaloid 
cells with indistinct cell border (Fig. 1). The nuclei are 
hyperchromatic with high nuclear-to-cytoplasmic ratio. 
The cells form sheets, nests and cords with sharply de-
fined borders. Excessive mitosis and apoptosis as well 
as comedo-type necrosis are observed. These carcino-
mas also show  a distinct immunohistochemical profile 
namely, a strong and diffuse p16 reactivity, very high 
Ki-�7 labeling scores (Fig. 1) and negative or week 
staining with p53. A hybrid form of NKSCC in which 
the basaloid tumor cells show focal and partial kerati-
nocytic maturation has been described by El-Mofty et 
al, (13) (Fig. 2). This hybrid variant was shown to be 
HPV related and to also have a favorable clinical outco-
me (11). 
p1� over expression is now considered a surrogate marker 
for HPV-related NKSCC of the OP (7,14). p16 is a cell 
cycle protein associated with tumor suppression by the 
retinoblastoma pathway. It inhibits hyperphosphorilation 
of retinoblastoma protein (pRb) thus preventing its disso-
ciation from the transcription factor E2F and the subse-
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Fig. 1. A) Nonkeratinizing squamous cell carcinoma. Sheets and large nests of tumor cells are seen with well defined borders and 
central comedo necrosis. B) Higher magnification showing small ovoid and spindle shaped tumor cells with hyperchromatic nuclei and 
indistinct cell bordrs. C) Strong and diffuse p16 immunostaining, both nuclear and cytoplasmic. D) Ki-�7stain showing high labeling 
score of more than 80%.
Fig. 2. A) Nonkeratinizing squamous cell carcinoma with focal areas of keratinocytic maturation  (hybrid variant). B) Nonkeratinizing hybrid 
variant with peripheral partial maturation of basaloid cells.
quent progression of the S phase of the cell cycle (15,16). 
HPV E7 oncoprotein interacts with pRb active form 
resulting in its functional inactivation. The paradoxical 
overexpression of an inhibitory protein in actively repli-
cating neoplastic cells is thought to result from feed-back 
control secondary to pRb deregulation (17,18). 
It has been shown that accurately identifying the nonk-
eratinizing morphologic features and its hybrid variant 
in oropharyngeal squamous cell carcinomas can be used 
as predictor of favorable clinical outcome (19). The non-
keratinizing morphology is significantly more likely to 
be HPV and p1� positive than KSCC, and to have bet-
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ter overall survival (OS) and disease specific survival 
(DSS) with a p value of<0.001 and 0.01 respectively (19). 
It was also shown that p1� overexpression in oropharyn-
geal SCC is associated with HPV positivity and has sig-
nificantly better patient outcome (20). The pattern of p16 
immunohistochemical staining that correlates with tran-
scriptionally active HPV and better patient outcome is 
strong and diffuse both nuclear and cytoplasmic in more 
than 75% of the tumor cells (Fig. 1) (20,21). 
Because of the observed disparity in clinical outcome of 
squamous cell carcinomas consequent to their HPV sta-
tus, there are ongoing clinical investigations to test the 
efficacy of altering treatment paradigms in documented 
HPV- related tumors. Multi-institutional clinical trials 
are underway to determine the feasibility of de-esca-
lated treatment modalities in these cases. It is therefore 
of importance that HPV status should be reliably and 
accurately determined. Detection p1� overexpression 
by immunohistochemistry is the most commonly used 
technique for this purpose. However in rare occasions 
p1� is not specific. Another common detection method 
is in situ hybridization (ISH) for HPV DNA. While 
highly specific it is not very sensitive. On the other hand, 
PCR analysis for HPV DNA is highly sensitive but not 
necessarily specific. Detecting viral DNA by PCR does 
not indicate whether the virus is trancriptionally active 
(driver) or a bystander (passenger). 
E�/E7 mRNA expression is considered the “gold stand-
ard” for identification of clinically significant HPV infec-
tion in tumor specimens. Reverse transcriptase polymer-
ase chain reaction (RT-PCR) and real-time quantitative 
RT-PCR (RT-qPCR) are the main methods used for de-
tection and quantitation of E�/E7 mRNA (22,23). More 
recently, an in situ hybridization method has been de-
veloped for detection of transcriptionally-active HPV in 
head and neck squamous cell carcinomas. ISH for E�/E7 
mRNA is a slide-based chromogenic assay that has been 
developed under the name RNA scope (Advanced cell di-
agnostics, Inc., Hayward, CA) (24,25). Results from HPV 
E�/E7 mRNA ISH were found to be highly concordant 
with p1� immunohistochemistry and RT-qPCR (24,25).
A small minority of HPV+ OP SCC show atypical clini-
cal behavior following treatment including poor OS, 
DSS and Disease free survival (DFS) (12,26,27). Some 
cases may be associated with multicentric disease in the 
mucosa of the upper aerodigestive tract excluding the 
oral cavity. The reported sites of involvement include 
the larynx, nasopharynx and sinonasal tract (28). Also, 
on rare occasion HPV+ OP SCC was reported to have 
multiple distant metastasis to unusual sites including 
the skin brain, gastrointestinal tract and intra-abdomi-
nal lymph nodes (28,29) The interval from completion 
of therapy to onset of distant metastasis ranged from 
4- 11 (28) and 2-52 (29) months with a median of onset 
7 and 18 months respectively (28,29).  
The exact causal mechanisms involved in poor clini-
cal outcome and patient survival in a minority of HPV 
positive SCC of the oropharynx are not clear. However, 
certain relevant molecular profiles have been proposed. 
These include over-expression of Bcl2, EGFR, and 
BclxL, (27,30,31). EGFR is a transmembrane tyrosine 
kinase, its function affects cell cycle progression, apop-
tosis, angiogenesis, tumor cell mobility and metastasis. 
Over expression of EGFR was shown to be associated 
with poor OS and DFS in HPV +, p1� + SCC of the 
oropharynx (30,31). Similarly over-expression of the 
antiapoptotic proteins Bcl2 and BclxL was shown to be 
associated with poor OS and DFS as well as DSS in 
HPV + OPSCC (27,31) these proteins are known to con-
fer resistance to chemotherapy and radiation therapy of 
head and neck SCC. It has also been documented that 
patients who continue to smoke after treatment have a 
significantly worse DSS than those who were past or 
never smokers (12,31).
HPV Related squamous cell carcinoma of the 
oral cavity 
Unlike the OP the oral cavity proper is a rare site for 
HPV related SCC.  El-Mofty and LU (7), using PCR 
and p1� immunostain, have shown in a cohort of young 
patients who are 40 years of age or younger that the 
prevalence of HPV related SCC of the palatine tonsils 
was (91%) 10/11 while in the oral cavity the prevalence 
was (0%) 0/15. However, considerable variations in the 
prevalence of HPV in oral SCC have been reported in 
the literature. These variations may be attributable to 
differences in specificity and sensitivity of the tests 
used and whether the identified virus is a “driver” or a 
“passenger” in these tumors. Prevalence may also vary 
by geographic distribution of the studied cases. A range 
of between 0%-11% has been reported (7,32-35). HPV+ 
oral SCC, unlike those in the OP, do not exhibit non-
keratinizing morphology. The significance of HPV in 
oral SCC and its relationship to treatment outcome and 
patient’s survival is currently not known. 
HPV-Related SCC variants  
The great majority of HPV relate SCC of the OP is 
nonkeratinizing as described above. However, more re-
cently increasing numbers of variants of squamous cell 
carcinoma, that are HPV-positive, are reported in the 
oropharynx as well as in other head and neck sites. As 
a result, several clinical and pathologic questions have 
emerged. Importantly, whether the virus is biologically 
active and involved in the pathogenesis of these tumors, 
and whether there are clinical implications with regard 
to patient outcome and treatment modality changes that 
may be needed in HPV related variants. Examples of 
HPV-related squamous cell carcinoma variants that 
will be addressed here include: basaloid squamous cell 
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Fig. 3. Basaloid squamous cell carcinoma. A) Illustrates biphasic 
pattern with conventional dysplastic squamous surface component 
associated with basaloid elements (arrow heads) and conventional 
squamous cell carcinoma intimately associated with basaloid com-
ponent (arrow). B) Closely packed basaloid cells forming a "jigsaw 
puzzle" appearance. Microcystic cribriform-like pattern is also ob-
served.
carcinoma, undifferentiated carcinoma, papillary squa-
mous carcinoma, small cell carcinoma and keratinizing 
squamous cell carcinoma. Some investigations have 
suggested favorable prognosis in some HPV positive 
variants, analogous to that of the nonkeratinizing car-
cinoma, while others showed poorer outcome. So far 
the number of studies on this subject is limited and the 
number of cases evaluated in each investigation is few. 
Because of this, it is prudent that at this stage, not to al-
ter management protocols as a result of identification of 
HPV in these variants and to await additional studies.
 
Basaloid squamous carcinoma (BSCC)
In the upper aerodigestive tract, BSCC is rare vari-
ant of conventional SCC. It occurs more commonly in 
the hypopharynx and larynx and less frequently in the 
oropharynx. Like SCC the tumor is typically associated 
with traditional risk factors like tobacco smoking and 
alcohol abuse. It is generally considered a high grade 
malignant neoplasm with poor prognosis. Microscopi-
cally, it is characterized by a biphasic pattern. A ba-
saloid component intimately associated with elements of 
keratinizing SCC. The basaloid cells are small, crowded 
with hyperchromatic round nuclei and scant cytoplasm. 
They form sheets and lobules that produce a “jigsaw 
puzzle” growth pattern with cystic spaces containing 
PAS –positive myxoid material. Stromal hyalization 
may be present (Fig. 3). The squamous component is 
either surface SCC or severe dysplasia in addition to 
focal abrupt squamous differentiation within the basal 
cell areas (Fig. 3). These microscopic features are dis-
tinct from but may be confused with those of NK SCC 
as described above. 
A causal relationship between HPV and some cases 
BSCC has been documented in the upper aerodigestive 
tract. Chernock et al, (36) using ISH for HPV DNA and 
p16 immunohistochemistry found that 75% of oroph-
ryngeal BSCC are HPV related while none (0%) of 1� 
laryngeal/hypopharyngeal tumors were positive (36). 
Using PCR for HPV 1� DNA as well as p1� immunos-
taining, Begum and Westra (37) documented HPV in 
76% of oropharyngeal BSCC and in 6% of tumors in 
non-oropharyngeal sites. In both studies (36,37) the 
overall survival was significantly better in HPV posi-
tive tumors than in the HPV negative ones with p< 0.05 
and <0.0001 respectively.
Undifferentiated carcinoma (lymphoepithelial, 
nasopharyngeal type)
In the head and neck undifferentiated carcinoma 
(UDCa) is best recognized in the nasopharynx where 
it is referred to by a variety of names including; lym-
phoepithelioma, nasopharyngeal type undifferentiated 
carcinoma and nonkeratinizing undifferentiated carci-
noma (WHO type III). Microscopically identical car-
cinomas are also identified in the oropharynx. While 
undifferentiated carcinoma of the nasopharynx has 
a strong etiologic relationship to Epstein-Barr virus 
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Fig. 4. Undifferentiated (lymphoepithelial) carcinoma. Undifferen-
tiated epithelial cells forming a syncytium and intermingled with 
lymphocytes and plasma cells. The tumor cells have large vesicular 
nuclei. 
(EBV) (38), undifferentiated carcinoma of the orophar-
ynx has recently been shown to be predominantly HPV 
and not EBV-related (39,40). 
The microscopic features of oropharyngeal undiffer-
entiated carcinoma are indistinguishable from those 
of the nasopharyngeal type as defined by the WHO. 
The tumors are composed of solid sheets, trabeculae, 
nests and single neoplastic epithelial cells intimately 
intermingled with lymphocytes and plasma cells. The 
epithelial tumor cells are large with indistinct cell bor-
ders forming a syncytium (Fig. 4). The nuclei are round 
to oval and vesicular with large central nucleoli. HPV 
DNA was identified in these tumors by PCR and ISH. 
Evidence for biologic activity of the virus was demon-
strated by p1� over- expression (39,40). The 3 year OS 
was found to be 55%, while the DSS was 100% (39).  No 
tumor recurrence was observed during a median follow 
up period of 23 months (40). The patient’s outcome in 
HPV positive undifferentiated carcinoma of the OP is 
generally favorable and comparable to that of the nonk-
eratinizing HPV-related squamous cell carcinoma.
Papillary squamous cell carcinoma 
Papillary squamous cell carcinoma (PSCC) is a poorly 
understood variant of SCC of the upper aerodigestive 
tract that is often confused with other exophytic mu-
cosal malignancies such as verrucous carcinoma and 
squamous cell carcinoma with verrucous features. As 
defined by the WHO, PSCC is characterized by a pre-
dominant papillary growth pattern with thin fibrovas-
cular cores covered by immature basaloid cells or dys-
plastic cells with minimal or no keratinization. PSSC is 
generally believed to have a better prognosis than con-
ventional squamous cell carcinoma.
Carcinomas with papillary growth pattern occurring 
in the uterine cervix, vulva and penis are commonly 
associated with High risk HPV particularly type 1�. 
Very limited number of studies has so far investigated 
the prevalence and significance of HPV in PSCC of the 
head and neck (41,42). Jo et al. (41) found that 15 of 31 
cases of PSCC of the head and neck were both p1� and 
HPV ISH positive. The majority of those (11 cases) were 
oropharyngeal. Patient outcome in HPV positive and 
negative tumors was not adequately investigated. 
In a recent study (42) we reviewed 48 cases of PSCC of 
the head and neck, 7 in the oral cavity 19 oropharynx 
and 22 in the larynx. Two morphologic types were iden-
tified: (1) a keratinizing type (K) in which the dysplas-
tic epithelium showed maturation trend with minimal 
surface parakeratin, and a nonkeratinizing (NK) type 
in which the papillae were covered with immature ba-
saloid cells (Fig. 5). An HPV relationship was identi-
fied by p1� immunoreactivity, HPV ISH and E� and E7 
mRNA ISH in a number of tumors (Fig. 5). The majori-
ties of these were found in younger patients, occurred 
more commonly in the OP, had NK morphology and 
were less likely to be p53 positive.  Disease specific sur-
vival (DSS) was favorable in all cases. The 5 years DSS 
for p1� positive and p1� negative cases was 80% and 70 
% respectively. No statistically significant difference in 
OS, DSS or disease-free survival (DFS) was found re-
garding tumor site, morphologic type or HPV relation-
ship. However, a trend towards better DFS was seen in 
patients with p1� positive/HPV positive tumors (42). 
Small cell (neuroendocrine) carcinoma
An association between HPV and neuroendocrine car-
cinoma of the oropharynx was shown in two recent 
studies (43,44). Bishop and Westra (43) found that 5 of 
9 cases of oropharyngeal small cell carcinoma (poorly 
differentiated neuroendocrine carcinoma) were HPV-
related. In 4 of these cases the tumors were associated 
with typical HPV-related SCC. All 5 tumors were p1� 
positive by immunohostochemistry and HPV positive 
by ISH. All cases showed a characteristic neuroendo-
crine immunophenotype, including reactivity to synap-
tophysin and /or chromogranin and CAM 5.2 and were 
negative for CK 5/�. Three of the 5 patients died within 
15 month of diagnosis (mean 10 months) with widely 
disseminated disease. Such outcome is in sharp contrast 
to the typical HPV-related nonkeratinizing SCC which 
is associated with a 3-year survival rate of up to 80% 
(12). Kraft et al. (44) reported 8 oropharyngeal neuroen-
docrine carcinomas that were HPV-related. Disease re-
currence occurred in 5 of � patients with available clini-
cal follow-up, with 3 developing metastasis to bone, 
lung, pleura, adrenal gland and pancreas.
HPV-related small cell carcinoma of the oropharynx 
shares common features with small cell neuroendocrine 
carcinoma of the uterine cervix. Both are associated 
with high risk HPV, commonly coexist with non-small 
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Fig. 5. Papillary squamous cell carcinoma. A) Keratinizing type, the dysplastic cells show maturation with minimal parakeratin formation. B) 
Nonkeratinizing type with immature basaloid cells. C) strong and diffuse p16 staining. D) Positive ISH for high risk-HPV DNA (blue nuclear 
staining).
cell squamous cell carcinoma and share the same ag-
gressive clinical behavior with early distant metastasis 
and poor overall survival (43-46). 
HPV-Related keratinizing squamous cell carci-
noma of the oropharynx
Classical KSCC of the OP is becoming much less fre-
quently encountered in some parts of the world includ-
ing the United States and some European countries. A 
very small minority of these are HPV related. In a re-
cent study we have found that only 7 of 54 (13%) KSCC 
of the OP overexpressed p1�. HPV E�/E7 RNA ISH was 
positive in 5 tested cases. The OS and DSS was signifi-
cantly better in the p16 positive than the p16 negative 
KSCC cases (p=0.01 and 0.04) respectively (47).
Discussion
The histopathologic features of keratinizing SCC of the 
upper aerodigestive tract have been used by Patholo-
gists as tools for prediction of tumor behavior and pa-
tient prognosis. Consequently, Clinicians have relied on 
this information for determining treatment modalities 
to be used in each particular case.  The greatest major-
ity of these keratinizing neoplasms  shared morphologic 
risk features that are used to classify them in a range 
of grades, from low to high.  Less frequently, variant 
forms of KSCC such as BSCC, PSCC, adenosquamous 
carcinoma, spindle cell carcinoma and UCa are encoun-
tered. These variants have distinct morphology and 
clinical behavior and are not graded. 
Within the last few decades an HPV related nonkerati-
nizing variant of SCC was identified. The majority of 
which occurred in the oropharynx. The neoplastic cells 
in these tumors show an immature basaloid appearance 
and are mitotically active. Such phenotype is not lim-
ited to oropharyngeal sites but it is also observed in oth-
er HPV related tumors in variety of sites including the 
sinonasal tract, larynx the and anogenital sites (48,49).
The exact molecular mechanisms underlying the ex-
pression of this specific histopathologic phenotype are 
not clear. It is possible that interactions between HPV 
oncoproteins and cell cycle mediators may play a role. It 
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is known that high risk HPV oncoproteins, particularly 
E� and E7, interfere with Rb and p53 functions leading 
to cell cycle  progression, cell immortalization, suppres-
sion  of apoptosis and essentially uncoupling of prolifer-
ation and maturation. It is conceivable that these chang-
es may be responsible for the characteristic immature 
basaloid appearance of the tumor cells. Chromosomal 
instability is another property of HPV oncogenesis. It is 
likely that additional mutations may be responsible for 
the development of those rare microscopic SCC variants 
discussed above.    
As the numbers of reported HPV positive head and neck 
squamous cell carcinoma variants are increasing, particu-
larly in the oropharynx, it is of importance to establish the 
status of the virus in the tumors cells and to distinguish 
between a causal agent “driver” and a bystander “pas-
senger”. Currently, the number of cases of SCC variants 
with established HPV causal relationship is still limited. 
Based on these studies, there is some evidence to suggest 
that variants such as BSCC, undifferentiated carcinoma 
and PSCC may have favorable prognosis similar to that of 
conventional NKSCC and better than their HPV negative 
counterparts. On the other hand, HPV related small cell 
carcinoma has been shown to be associated with early 
distant metastasis and poor overall survival. More over a 
minority of NKSCC of the oropharynx have been recent-
ly found to be associated with atypical clinical behavior 
following treatment, including poor OS, DSS and DFS 
(12,2�,27).It is thus too early to reach a defi nite conclu-
sion regarding the biologic behavior of HPV-related SCC 
morphologic variants. Surgeons and oncologists should 
be warned that HPV status in these tumors should not be 
used, at this time, as a justification for considering de-
escalation of conventional therapy.    
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